A recent study has found that the use of febuxostat among gout patients is associated with an increased risk of cardiovascular events. The study suggests that patients taking this medication should be monitored closely for potential cardiovascular complications. It is important for healthcare providers to consider this risk when prescribing febuxostat to patients with gout. The findings highlight the need for further research and monitoring of cardiovascular outcomes in patients using this medication.
Source link
Febuxostat Use Among Gout Patients Linked to Increased Cardiovascular Risk in new study
